METFORMIN Side Effects

7020148-5 | Weight Decreased
on Sep 18, 2010 Female patient from ALGERIA , weighting 136.7 lb, was diagnosed with type 2 diabetes mellitus and was treated with Metformin (View Usage). Patient experienced the following unwanted or unexpected effects: weight decreased. Metformin dosage: 200 Mg, Qd. During the same period patient was treated with INSULIN DETEMIR FLEXPEN (28 Iu, Qd) (View Insulin Detemir Flexpen Review and Insulin Detemir Flexpen Label ).

7018749-3 | Alveolitis Allergic
Patient was taking Metformin (View Usage). Patient had the following side effects: alveolitis allergic on Sep 15, 2010 from NETHERLANDS Additional patient health information: Female patient , weighting 125.7 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Metformin dosage: . During the same period patient was treated with ADALIMUMAB (View Adalimumab Review and Adalimumab Label ), ROSUVASTATIN (View Rosuvastatin Review and Rosuvastatin Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), RISEDRONATE SODIUM (View Risedronate Sodium Review and Risedronate Sodium Label ). Patient was hospitalized.

7016134-1 | Alanine Aminotransferase Increased, Cardiac Arrest, Cinchonism, Cognitive Disorder, Hepatic Congestion, Hepatocellular Injury, International Normalised Ratio Increased, Metabolic Acidosis
Adverse event was reported on Sep 23, 2010 by a Female patient taking Metformin (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 76 years of age, weighting 202.8 lb, After Metformin was administered, patient had the following side effects: alanine aminotransferase increased, cardiac arrest (What is cardiac arrest?), cinchonism, cognitive disorder, hepatic congestion, hepatocellular injury, international normalised ratio increased, metabolic acidosis. During the same period patient was treated with QUININE (View Quinine Review and Quinine Label ).

7008816-2 | Lactic Acidosis, Renal Failure Acute, Shock
on Sep 08, 2010 Female patient from GERMANY , 71 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Metformin (View Usage). Patient experienced the following unwanted or unexpected effects: lactic acidosis, renal failure acute, shock. Metformin dosage: 1x1000mg. During the same period patient was treated with VICTOZA (1x0.6mg) (View Victoza Review and Victoza Label ). Patient was hospitalized.


7008815-0 | Lactic Acidosis, Renal Failure Acute, Shock
on Sep 08, 2010 Female patient from GERMANY , 71 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Metformin (View Usage). Patient had the following side effects: lactic acidosis, renal failure acute, shock. Metformin dosage: 1x1000mg. During the same period patient was treated with VICTOZA (1x0.6mg) (View Victoza Review and Victoza Label ). Patient was hospitalized.

7004657-0 | Hyperkalaemia, Hypothermia, Lactic Acidosis, Renal Failure Acute, Shock
Patient was taking Metformin (View Usage). After Metformin was administered, patient had the following side effects: hyperkalaemia, hypothermia (What is hypothermia?), lactic acidosis, renal failure acute, shock on Sep 07, 2010 from GERMANY Additional patient health information: Female patient , 71 years of age, was diagnosed with type 2 diabetes mellitus and. Metformin dosage: 1000 Mg, Qd. During the same period patient was treated with VICTOZA (0.6 Mg, Qd) (View Victoza Review and Victoza Label ). Patient was hospitalized.

7003398-3 | Abdominal Discomfort, Dizziness, Weight Decreased
Adverse event was reported on Sep 01, 2010 by a Female patient taking Metformin (View Usage) (Dosage: 500mg, Bid,) was diagnosed with blood glucose increased and. Location: UNITED STATES , 81 years of age, weighting 162.0 lb, Patient experienced the following unwanted or unexpected effects: abdominal discomfort, dizziness (What is dizziness?), weight decreased. During the same period patient was treated with ZOCOR (0.5mg, Daily, Oral) (View Zocor Review and Zocor Label ), INDAPAMIDE (View Indapamide Review and Indapamide Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ).

6986795-1 | Hepatitis, Purpura, Pyrexia, Renal Impairment
on Sep 01, 2010 Female patient from SINGAPORE , 84 years of age, was treated with Metformin (View Usage). Patient had the following side effects: hepatitis (What is hepatitis?), purpura, pyrexia, renal impairment. Metformin dosage: Dosage Not Stated. Patient was hospitalized.

6986794-X | Hepatitis, Purpura, Pyrexia, Renal Impairment
on Sep 01, 2010 Female patient from SINGAPORE , 84 years of age, was treated with Metformin (View Usage). After Metformin was administered, patient had the following side effects: hepatitis (What is hepatitis?), purpura, pyrexia, renal impairment. Metformin dosage: Dosage Not Stated. Patient was hospitalized.

6986688-X | Hypotension, Lactic Acidosis, Myocardial Infarction, Renal Failure Acute
Patient was taking Metformin (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension, lactic acidosis, myocardial infarction, renal failure acute on Sep 01, 2010 from ITALY Additional patient health information: Male patient , 53 years of age, was diagnosed with diabetes mellitus and. Metformin dosage: 850mg Three Times A Day. During the same period patient was treated with DOPAMINE HCL (20 Mcg/kg/min) (View Dopamine Hcl Review and Dopamine Hcl Label ).

6986687-8 | Hypotension, Lactic Acidosis, Myocardial Infarction, Renal Failure Acute
Adverse event was reported on Sep 01, 2010 by a Male patient taking Metformin (View Usage) (Dosage: 850mg Three Times A Day) was diagnosed with diabetes mellitus and. Location: ITALY , 53 years of age, Patient had the following side effects: hypotension, lactic acidosis, myocardial infarction, renal failure acute. During the same period patient was treated with DOPAMINE HCL (20 Mcg/kg/min) (View Dopamine Hcl Review and Dopamine Hcl Label ).

6984502-X | Aggression, Mood Swings, Self Injurious Behaviour
on Sep 01, 2010 Male patient from UNITED KINGDOM , 22 years of age, was diagnosed with diabetes mellitus and was treated with Metformin (View Usage). After Metformin was administered, patient had the following side effects: aggression, mood swings, self injurious behaviour. Metformin dosage: Unk. During the same period patient was treated with ACETAMINOPHEN (500 Mg, Unk) (View Acetaminophen Review and Acetaminophen Label ).

6980201-9 | Lactic Acidosis, Renal Failure Acute
on Aug 31, 2010 Male patient from ITALY , 53 years of age, was diagnosed with diabetes mellitus and was treated with Metformin (View Usage). Patient experienced the following unwanted or unexpected effects: lactic acidosis, renal failure acute. Metformin dosage: 850 Mg, Tid.

6969922-1 | Aggression, Mood Swings, Self Injurious Behaviour
Patient was taking Metformin (View Usage). Patient had the following side effects: aggression, mood swings, self injurious behaviour on Sep 01, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 22 years of age, was diagnosed with diabetes mellitus and. Metformin dosage: .

6969879-3 | Lactic Acidosis, Renal Failure Acute
Adverse event was reported on Aug 25, 2010 by a Male patient taking Metformin (View Usage) (Dosage: 850 Mg, Tid) . Location: ITALY , 53 years of age, After Metformin was administered, patient had the following side effects: lactic acidosis, renal failure acute.

6962234-1 | Hepatitis
on Aug 18, 2010 Male patient from UNITED KINGDOM , 56 years of age, was diagnosed with diabetes mellitus and was treated with Metformin (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis (What is hepatitis?). Metformin dosage: . During the same period patient was treated with FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), GLUCOPHAGE XR (500mg, Twice Daily) (View Glucophage Xr Review and Glucophage Xr Label ), LIPITOR (View Lipitor Review and Lipitor Label ), NATEGLINIDE (View Nateglinide Review and Nateglinide Label ), PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ), PROTON PUMP INHIBITOR (View Proton Pump Inhibitor Review and Proton Pump Inhibitor Label ).

6961596-9 | Hepatitis
on Aug 19, 2010 Male patient from UNITED KINGDOM , 56 years of age, was diagnosed with diabetes mellitus and was treated with Metformin (View Usage). Patient had the following side effects: hepatitis (What is hepatitis?). Metformin dosage: . During the same period patient was treated with FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), LIPITOR (View Lipitor Review and Lipitor Label ), NATEGLINIDE (View Nateglinide Review and Nateglinide Label ), PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ), PROTON PUMP INHIBITORS (View Proton Pump Inhibitors Review and Proton Pump Inhibitors Label ).

6961595-7 | Hepatitis
Patient was taking Metformin (View Usage). After Metformin was administered, patient had the following side effects: hepatitis (What is hepatitis?) on Aug 19, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 56 years of age, was diagnosed with diabetes mellitus and. Metformin dosage: . During the same period patient was treated with FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), LIPITOR (View Lipitor Review and Lipitor Label ), NATEGLINIDE (View Nateglinide Review and Nateglinide Label ), PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ), PROTON PUMP INHIBITORS (View Proton Pump Inhibitors Review and Proton Pump Inhibitors Label ).

6960077-6 | Cholestasis, Cytolytic Hepatitis, Hepatic Failure, Jaundice
Adverse event was reported on Aug 19, 2010 by a Female patient taking Metformin (View Usage) (Dosage: 1 Df, Unk) was diagnosed with dyslipidaemia and. Location: FRANCE , 76 years of age, Patient experienced the following unwanted or unexpected effects: cholestasis, cytolytic hepatitis, hepatic failure, jaundice (What is jaundice?). During the same period patient was treated with FENOFIBRATE (160 Mg, Unk) (View Fenofibrate Review and Fenofibrate Label ), NIDREL 20 MG (View Nidrel 20 Mg Review and Nidrel 20 Mg Label ), ALLOPURINOL (200 Mg, Unk) (View Allopurinol Review and Allopurinol Label ), AMAREL (1 Df, Unk) (View Amarel Review and Amarel Label ), TENORMIN (100 Mg, Unk) (View Tenormin Review and Tenormin Label ), KARDEGIC (75 Mg, Unk) (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

6956814-7 | Ascites, Cholestasis, Cytolytic Hepatitis, Hepatic Cirrhosis, Hepatic Failure, Liver Disorder, Oedema
on Aug 13, 2010 Female patient from FRANCE , 76 years of age, was treated with Metformin (View Usage). Patient had the following side effects: ascites, cholestasis, cytolytic hepatitis, hepatic cirrhosis, hepatic failure, liver disorder, oedema. Metformin dosage: 1df, Daily, Oral. During the same period patient was treated with TENORMIN (100 Mg, Daily, Oral) (View Tenormin Review and Tenormin Label ), LIPANTHYL (160 Mg, Daily, Oral) (View Lipanthyl Review and Lipanthyl Label ), NIDREL (20 Mg, Daily, Oral) (View Nidrel Review and Nidrel Label ), ALLOPURINOL (200 Mg, Daily, Oral) (View Allopurinol Review and Allopurinol Label ), AMAREL (1df, Daily, Oral) (View Amarel Review and Amarel Label ), KARDEGIC (75 Mg, Daily, Oral) (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

6947121-7 | Blood Creatine Phosphokinase Increased, Confusional State, Miosis, Renal Impairment, Sepsis, Somnolence
on Aug 12, 2010 Male patient from , 79 years of age, was diagnosed with diabetes mellitus, hypercholesterolaemia, polyuria, fluid overload, phantom pain, breakthrough pain, left ventricular failure and was treated with Metformin (View Usage). After Metformin was administered, patient had the following side effects: blood creatine phosphokinase increased, confusional state, miosis, renal impairment, sepsis (What is sepsis?), somnolence. Metformin dosage: 500mg, Tid, Oral. During the same period patient was treated with ATORVASTATIN (20mg, Daily, Oral) (View Atorvastatin Review and Atorvastatin Label ), BENDROFLUMETHIAZIDE (2.5mg - Daily - Oral) (View Bendroflumethiazide Review and Bendroflumethiazide Label ), FUROSEMIDE (40mg - Daily - Oral) (View Furosemide Review and Furosemide Label ), OXYCONTIN (40mg - Bid - Oral) (View Oxycontin Review and Oxycontin Label ), OXYCODONE HCL (10mg - Qid - Oral) (View Oxycodone Hcl Review and Oxycodone Hcl Label ), RAMIPRIL (7.5mg - Daily - Oral) (View Ramipril Review and Ramipril Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DOXYCYCLINE (View Doxycycline Review and Doxycycline Label ). Patient was hospitalized.

6940460-5 | Abdominal Pain Upper, Abnormal Behaviour, Amnesia, Constipation, Dysuria, Fatigue, Hand Fracture, Liver Disorder
Patient was taking Metformin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, abnormal behaviour, amnesia, constipation (What is constipation?), dysuria, fatigue, hand fracture, liver disorder on Aug 05, 2010 from UNITED STATES Additional patient health information: Male patient , 56 years of age, weighting 200.0 lb, was diagnosed with diabetes mellitus, neuropathy peripheral, sinusitis (What is sinusitis?) and. Metformin dosage: 4000mg, Daily,. During the same period patient was treated with GABAPENTIN (800mg, Qid, Oral) (View Gabapentin Review and Gabapentin Label ), NEURONTIN (600mg, Bid, Oral) (View Neurontin Review and Neurontin Label ), FENTANYL CITRATE (0.25mg, Q3d, Transdermal) (View Fentanyl Citrate Review and Fentanyl Citrate Label ), KEFLEX CAPSULE (500mg, Tid, Oral) (View Keflex Capsule Review and Keflex Capsule Label ), VICODIN (10/650mg, 1.5 Tab Tid, Oral) (View Vicodin Review and Vicodin Label ), LANTUS (View Lantus Review and Lantus Label ), HUMALOG (View Humalog Review and Humalog Label ), FLUTICASONE PROPIONATE (View Fluticasone Propionate Review and Fluticasone Propionate Label ).

6937802-3 | Blood Glucose Increased, Product Substitution Issue
Adverse event was reported on Aug 20, 2010 by a Female patient taking Metformin (View Usage) (Dosage: 500 Mg Bid Po) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 77 years of age, Patient had the following side effects: blood glucose increased, product substitution issue.

6924437-1 | Hepatotoxicity, Weight Decreased
on Jul 29, 2010 Male patient from UNITED STATES , 61 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Metformin (View Usage). After Metformin was administered, patient had the following side effects: hepatotoxicity, weight decreased. Metformin dosage: 500 Mg, Bid, Oral. During the same period patient was treated with NIASPAN (500 Mg;) (View Niaspan Review and Niaspan Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6913677-3 | Confusional State, Miosis, Renal Impairment, Sepsis, Somnolence
on Jul 20, 2010 Male patient from , 79 years of age, was diagnosed with diabetes mellitus, hypercholesterolaemia, polyuria, fluid overload, phantom pain, breakthrough pain, left ventricular failure and was treated with Metformin (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, miosis, renal impairment, sepsis (What is sepsis?), somnolence. Metformin dosage: 500mg, Tid, Oral. During the same period patient was treated with ATORVASTATIN CALCIUM (20mg, Daily, Oral) (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), BENDROFLUMETHIATIDE (2.5mg-daily-oral) (View Bendroflumethiatide Review and Bendroflumethiatide Label ), FUROSEMIDE (40mg-daily-oral) (View Furosemide Review and Furosemide Label ), OXYCONTIN (40mg-bid-oral) (View Oxycontin Review and Oxycontin Label ), OXYCODONE HCL (10mg-qid-oral) (View Oxycodone Hcl Review and Oxycodone Hcl Label ), RAMIPRIL (7.5mg-daily-oral) (View Ramipril Review and Ramipril Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DOXYCYCLINE (View Doxycycline Review and Doxycycline Label ). Patient was hospitalized.

6829835-2 | Liver Disorder, Renal Failure
Patient was taking Metformin (View Usage). Patient had the following side effects: liver disorder, renal failure on Jun 21, 2010 from UNITED STATES Additional patient health information: Male patient , 82 years of age, weighting 200.0 lb, was diagnosed with diabetes mellitus, diabetic neuropathy and. Metformin dosage: . During the same period patient was treated with NEURONTIN (Oral) (View Neurontin Review and Neurontin Label ), VICODIN (Oral) (View Vicodin Review and Vicodin Label ).

6829820-0 | Abdominal Pain Upper, Aggression, Amnesia, Constipation, Dysuria, Fatigue, Hand Fracture
Adverse event was reported on Jun 21, 2010 by a Male patient taking Metformin (View Usage) (Dosage: ) was diagnosed with diabetes mellitus, gastric disorder, neuropathy peripheral, sinusitis (What is sinusitis?) and. Location: UNITED STATES , 56 years of age, weighting 200.0 lb, After Metformin was administered, patient had the following side effects: abdominal pain upper, aggression, amnesia, constipation (What is constipation?), dysuria, fatigue, hand fracture. During the same period patient was treated with GABAPENTIN CAPSULE (GREENSTONE) (800mg, Qid, Oral) (View Gabapentin Capsule (greenstone) Review and Gabapentin Capsule (greenstone) Label ), NEURONTIN (Oral) (View Neurontin Review and Neurontin Label ), FENTANYL CITRATE (0.25mg, Q3d, Transdermal) (View Fentanyl Citrate Review and Fentanyl Citrate Label ), KEFLEX (1500mg, Tid, Oral) (View Keflex Review and Keflex Label ), VICODIN (10/650mg, 1.5 Tab Tid, Oral) (View Vicodin Review and Vicodin Label ).

6821530-9 | Blood Glucose Increased, Hypoglycaemia, Malaise
on Jun 16, 2010 Male patient from UNITED STATES , 58 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Metformin (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, hypoglycaemia, malaise. Metformin dosage: 100mg, Bid,. During the same period patient was treated with GLIPIZIDE (100mg, Daily,) (View Glipizide Review and Glipizide Label ), PRICKLY PEAR CACTUS (Daily) (View Prickly Pear Cactus Review and Prickly Pear Cactus Label ).

6784695-3 | Muscular Weakness, Rhabdomyolysis
on Jun 14, 2010 Male patient from ITALY , 25 years of age, was diagnosed with hyperinsulinaemia, mental disorder and was treated with Metformin (View Usage). Patient had the following side effects: muscular weakness, rhabdomyolysis. Metformin dosage: . During the same period patient was treated with AMISULPRIDE (View Amisulpride Review and Amisulpride Label ).

6765335-6 | Lactic Acidosis, Renal Failure Acute
Patient was taking Metformin (View Usage). After Metformin was administered, patient had the following side effects: lactic acidosis, renal failure acute on May 28, 2010 from IRAN (ISLAMIC REPUBLIC OF) Additional patient health information: Male patient , 42 years of age, weighting 187.4 lb, was diagnosed with diabetes mellitus and. Metformin dosage: 500 Mg, Bid. During the same period patient was treated with CREATINE MONOHYDRATE (5 G, Qid) (View Creatine Monohydrate Review and Creatine Monohydrate Label ).

6761902-4 | Abdominal Pain, Blood Glucose Increased, Constipation, Flatulence, Haemorrhage, Proctalgia
Adverse event was reported on May 28, 2010 by a Female patient taking Metformin (View Usage) (Dosage: 1 Tablet Per Day) was diagnosed with diabetes mellitus, irritable bowel syndrome (What is irritable bowel syndrome?), hypertension and. Location: BRAZIL , 48 years of age, weighting 189.6 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), blood glucose increased, constipation (What is constipation?), flatulence, haemorrhage, proctalgia. During the same period patient was treated with ZELMAC (View Zelmac Review and Zelmac Label ), CERAZETTE (1 Tablet Per Day) (View Cerazette Review and Cerazette Label ), ABLOK PLUS (1 Tablet Per Day) (View Ablok Plus Review and Ablok Plus Label ).

6761368-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Fatigue, Gamma-glutamyltransferase Increased
on May 21, 2010 Male patient from , 54 years of age, weighting 183.0 lb, was diagnosed with type 2 diabetes mellitus, hyperlipidaemia, hypertriglyceridaemia, hyperuricaemia, hypertension and was treated with Metformin (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, fatigue, gamma-glutamyltransferase increased. Metformin dosage: 500mg, Qd, Oral. During the same period patient was treated with CRESTOR (10mg, Qd, Oral) (View Crestor Review and Crestor Label ), JANUMET (50/1000mg, Bid, Oral) (View Janumet Review and Janumet Label ), ACTOS (15 Mg, Daily, Oral) (View Actos Review and Actos Label ), OMACOR (1000mg,qid, Oral) (View Omacor Review and Omacor Label ), ALLOPURINOL (150mg,daily, Oral) (View Allopurinol Review and Allopurinol Label ), RASILEZ (150mg, Daily, Oral) (View Rasilez Review and Rasilez Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), METOHEXAL SUCC 95 (View Metohexal Succ 95 Review and Metohexal Succ 95 Label ). Patient was hospitalized.

6752726-2 | Arterial Occlusive Disease, Chest Pain, Surgical Procedure Repeated
on May 17, 2010 Male patient from UNITED STATES , 50 years of age, weighting 157.0 lb, was treated with Metformin (View Usage). After Metformin was administered, patient had the following side effects: arterial occlusive disease, chest pain (What is chest pain?), surgical procedure repeated. Metformin dosage: 1000mg, Bid. During the same period patient was treated with METOPROLOL (25mg, Daily) (View Metoprolol Review and Metoprolol Label ), LIPITOR (10mg, Daily, Oral) (View Lipitor Review and Lipitor Label ), GLIPIZIDE (10mg, Bid) (View Glipizide Review and Glipizide Label ). Patient was hospitalized.

6715083-3 | Accommodation Disorder, Dacryostenosis Acquired, Vision Blurred
Patient was taking Metformin (View Usage). Patient experienced the following unwanted or unexpected effects: accommodation disorder, dacryostenosis acquired, vision blurred on Apr 23, 2010 from NETHERLANDS Additional patient health information: Male patient , 57 years of age, weighting 253.5 lb, was diagnosed with type 2 diabetes mellitus, hypercholesterolaemia and. Metformin dosage: . During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ).

6715082-1 | Accommodation Disorder, Dacryostenosis Acquired, Vision Blurred
Adverse event was reported on Apr 23, 2010 by a Male patient taking Metformin (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus, hypercholesterolaemia and. Location: NETHERLANDS , 57 years of age, weighting 253.5 lb, Patient had the following side effects: accommodation disorder, dacryostenosis acquired, vision blurred. During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ).

6715079-1 | Porphyria Acute
on Apr 23, 2010 Male patient from NETHERLANDS , 74 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Metformin (View Usage). After Metformin was administered, patient had the following side effects: porphyria acute. Metformin dosage: . During the same period patient was treated with METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ).

6715078-X | Porphyria Acute
on Apr 23, 2010 Male patient from NETHERLANDS , 74 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Metformin (View Usage). Patient experienced the following unwanted or unexpected effects: porphyria acute. Metformin dosage: . During the same period patient was treated with METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ).

6714566-X | Transaminases Increased, Vomiting
Patient was taking Metformin (View Usage). Patient had the following side effects: transaminases increased, vomiting on Apr 22, 2010 from GERMANY Additional patient health information: Female patient , 64 years of age, weighting 141.1 lb, was diagnosed with type 2 diabetes mellitus, hypercholesterolaemia, hypertension and. Metformin dosage: . During the same period patient was treated with FLUVASTATIN (View Fluvastatin Review and Fluvastatin Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), BYETTA (View Byetta Review and Byetta Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), CARMEN (View Carmen Review and Carmen Label ). Patient was hospitalized.

6714565-8 | Transaminases Increased, Vomiting
Adverse event was reported on Apr 22, 2010 by a Female patient taking Metformin (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus, hypercholesterolaemia, hypertension and. Location: GERMANY , 64 years of age, weighting 141.1 lb, After Metformin was administered, patient had the following side effects: transaminases increased, vomiting. During the same period patient was treated with FLUVASTATIN (View Fluvastatin Review and Fluvastatin Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), BYETTA (View Byetta Review and Byetta Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), CARMEN (View Carmen Review and Carmen Label ). Patient was hospitalized.

6703205-X | Acidosis, Acute Left Ventricular Failure, Blood Glucose Increased, Blood Lactic Acid Increased, Body Temperature Decreased
on Apr 16, 2010 Male patient from UNITED KINGDOM , 69 years of age, weighting 198.4 lb, was diagnosed with diabetes mellitus and was treated with Metformin (View Usage). Patient experienced the following unwanted or unexpected effects: acidosis, acute left ventricular failure, blood glucose increased, blood lactic acid increased, body temperature decreased. Metformin dosage: 1000 Mg, Bid. During the same period patient was treated with ASPIRIN (75 Mg, Qd) (View Aspirin Review and Aspirin Label ), FERROUS SULFATE TAB (200 Mg, Bid) (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), FRUSEMIDE (40 Mg, Qd) (View Frusemide Review and Frusemide Label ), QUETIAPINE (150 Mg, Bid) (View Quetiapine Review and Quetiapine Label ), RAMIPRIL (10 Mg, Qd) (View Ramipril Review and Ramipril Label ), SIMVASTATIN (40 Mg, Qd) (View Simvastatin Review and Simvastatin Label ), SPIRONOLACTONE (25 Mg, Qd) (View Spironolactone Review and Spironolactone Label ), DOCUSATE (100 Mg, Bid) (View Docusate Review and Docusate Label ). Patient was hospitalized.

6697504-8 | Condition Aggravated, Fibromyalgia
on Apr 07, 2010 Female patient from UNITED STATES , 67 years of age, was treated with Metformin (View Usage). Patient had the following side effects: condition aggravated, fibromyalgia. Metformin dosage: 500mg. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), HYZAAR (100/25) (View Hyzaar Review and Hyzaar Label ), LUMIGAN (Opthalmic) (View Lumigan Review and Lumigan Label ).

6678200-X | Nausea
Patient was taking Metformin (View Usage). After Metformin was administered, patient had the following side effects: nausea (What is nausea?) on Apr 08, 2010 from UNITED STATES Additional patient health information: Female patient , 52 years of age, weighting 203.0 lb, . Metformin dosage: .

6581663-1 | Cardiopulmonary Failure, Coma, Diabetic Nephropathy, Hyperkalaemia, Lactic Acidosis, Multi-organ Failure, Systemic Inflammatory Response Syndrome
Adverse event was reported on Feb 01, 2010 by a Female patient taking Metformin (View Usage) (Dosage: ) . Location: GERMANY , 85 years of age, weighting 149.9 lb, Patient experienced the following unwanted or unexpected effects: cardiopulmonary failure, coma, diabetic nephropathy, hyperkalaemia, lactic acidosis, multi-organ failure, systemic inflammatory response syndrome. During the same period patient was treated with DICLOFENAC (View Diclofenac Review and Diclofenac Label ). Patient was hospitalized.

6566545-3 | Bile Duct Stone, Pancreatitis
on Jan 12, 2010 Female patient from , 67 years of age, weighting 187.4 lb, was diagnosed with type 2 diabetes mellitus, rheumatoid arthritis (What is rheumatoid arthritis?), fibromyalgia and was treated with Metformin (View Usage). Patient had the following side effects: bile duct stone, pancreatitis. Metformin dosage: 1000mg, Aid, Oral. During the same period patient was treated with METHOTREXATE TABLET (10mg-weekly - Oral) (View Methotrexate Tablet Review and Methotrexate Tablet Label ), GLICLAZIDE (40mg-bid-oral) (View Gliclazide Review and Gliclazide Label ), ENDEP (10mg -daily-oral) (View Endep Review and Endep Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6565904-2 | Bile Duct Stone, Pancreatitis
on Jan 12, 2010 Female patient from , 67 years of age, weighting 189.4 lb, was diagnosed with type 2 diabetes mellitus, rheumatoid arthritis (What is rheumatoid arthritis?), fibromyalgia and was treated with Metformin (View Usage). After Metformin was administered, patient had the following side effects: bile duct stone, pancreatitis. Metformin dosage: 1000mg, Bid, Oral. During the same period patient was treated with METHOTREXATE (10 Mg Weekly, Oral) (View Methotrexate Review and Methotrexate Label ), GLICLAZIDE (40 Mg, Bid, Oral) (View Gliclazide Review and Gliclazide Label ), ENDEP (10mg, Daily, Oral) (View Endep Review and Endep Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), PARIET (View Pariet Review and Pariet Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6557294-6 | Dehydration, Diarrhoea, Enuresis, Gastroenteritis, Nausea, Neutropenia, Pneumonia, Salivary Hypersecretion
Patient was taking Metformin (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, diarrhoea, enuresis, gastroenteritis (What is gastroenteritis?), nausea (What is nausea?), neutropenia, pneumonia (What is pneumonia?), salivary hypersecretion on Jan 18, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 18 years of age, was diagnosed with weight decreased, schizophrenia, constipation (What is constipation?), salivary hypersecretion and. Metformin dosage: 250 Mg, Qd. During the same period patient was treated with CLOZARIL (350 Mg, Unk) (View Clozaril Review and Clozaril Label ), DOCUSATE (200 Mg, Unk) (View Docusate Review and Docusate Label ), HYOSCINE HBR HYT (300 Mg, Tid) (View Hyoscine Hbr Hyt Review and Hyoscine Hbr Hyt Label ), SENNA (15 Mg, Unk) (View Senna Review and Senna Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ). Patient was hospitalized.

6554152-8 |
Adverse event was reported on Jan 20, 2010 by a Female patient taking Metformin (View Usage) (Dosage: ) was diagnosed with gestational diabetes and. Location: UNITED KINGDOM , 36 years of age, weighting 143.3 lb, .

6553891-2 | Diarrhoea, Hypocalcaemia, Hypokalaemia, Hypomagnesaemia, Malaise, Muscle Spasms, Pain, Paraesthesia, Paraesthesia Oral
on Jan 19, 2010 Male patient from NORWAY , 57 years of age, was diagnosed with diabetes mellitus, type 2 diabetes mellitus and was treated with Metformin (View Usage). After Metformin was administered, patient had the following side effects: diarrhoea, hypocalcaemia, hypokalaemia, hypomagnesaemia, malaise, muscle spasms, pain (What is pain?), paraesthesia, paraesthesia oral. Metformin dosage: 0.5-1 Gram. During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ). Patient was hospitalized.

6552354-8 | Lactic Acidosis, Muscle Spasms
on Jan 07, 2010 Female patient from UNITED STATES , 14 years of age, weighting 121.3 lb, was treated with Metformin (View Usage). Patient experienced the following unwanted or unexpected effects: lactic acidosis, muscle spasms. Metformin dosage: 500mg, Oral.

6552347-0 | Hyperkalaemia
Patient was taking Metformin (View Usage). Patient had the following side effects: hyperkalaemia on Jan 07, 2010 from UNITED STATES Additional patient health information: Female patient , 73 years of age, weighting 330.7 lb, . Metformin dosage: . During the same period patient was treated with MELOXICAM (View Meloxicam Review and Meloxicam Label ), CEFACLOR (View Cefaclor Review and Cefaclor Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), CO FLUAMPICIL (View Co-fluampicil Review and Co-fluampicil Label ), HUMALOG (INSULIN HUMAN) (View Humalog (insulin Human) Review and Humalog (insulin Human) Label ), HUMALOG MIX 25 (INSULIN LISPRO) (View Humalog Mix 25 (insulin Lispro) Review and Humalog Mix 25 (insulin Lispro) Label ), LOPERAMIDE (View Loperamide Review and Loperamide Label ). Patient was hospitalized.